HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...
Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancerLargest real-world, ...
This article explores how advances in data, genomics and artificial intelligence are improving our ability to estimate ...
Following the acquisition of Paige in 2025, Tempus launches its new AI-powered, biomarker prediction solution for digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results